Literature DB >> 1164095

Absorption, distribution and excretion of trifluoperazine in rats.

N R West, W H Vogel.   

Abstract

In rats receiving a low oral dose (0.35 mg/kg p.o.) of trifluoperazine (TFP), a potent neuroleptic phenothiazine, the parent drug distribution was separate from that of its metabolite trifluoperazine sulfoxide (TFP-SO). This was not seen after intraperitoneal administration (i.p.) of the same or high dose (5mg/kg). TFP-SO was not detected in the brain, wheras TFP was significantly associated with microsomes when its brain level was highest. Absorption, distribution, metabolism, and dose dependent excretion procedded rapidly with 97% of a dose recovered 24 hr after p.o. treatment, only 6% in the urine and the remainder in feces with 87% of this metabolized to compounds other than TFP-SO. TFP and its metabolites arrived in feces via two pathways, largely the bile plus another route. The excretion pattern was unchanges with other drugs or after treatment for 3 wk, although excretion differed on the first day after i.p. and p.o. administration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164095

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  5 in total

1.  Kinetics of 35S-perazine in the bile fistula rat.

Authors:  U Breyer; I Jahns; G Irmscher; H Rassner; S Rehmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  Effects of a calmodulin inhibitor on bleomycin-induced lung inflammation in hamsters. Biochemical, morphometric, and bronchoalveolar lavage data.

Authors:  J M Nakashima; D M Hyde; S N Giri
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

3.  Radioimmunoassay for trifluoperazine in human plasma.

Authors:  K K Midha; J W Hubbard; J K Cooper; E M Hawes; S Fournier; P Yeung
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

4.  Regional localization of [(14)C]mescaline in rabbit brain after intraventricular administration : Effects of chlorpromazine and iproniazid pretreatment.

Authors:  N S Shah; O D Dulati; D A Powell; V Kleinburd
Journal:  Neurochem Res       Date:  1977-06       Impact factor: 3.996

5.  Inhibitory effects of UDP-glucuronosyltransferase (UGT) typical ligands against E. coli beta-glucuronidase (GUS).

Authors:  Ling Xiao; Dehui Chi; Guiju Sheng; Wenjuan Li; Penghui Lin; Sicheng Liang; Liangliang Zhu; Peipei Dong
Journal:  RSC Adv       Date:  2020-06-16       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.